Cargando...

Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Continuous treatment vs fixed duration of monotherapies and combinations of targeted agents are treatment options in relapsed chronic lymphocytic leukemia. The optimal choice of relapse treatment is dependent on the prior frontline therapy, duration of remission after frontline, genetic markers, and...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Hematology Am Soc Hematol Educ Program
Main Authors: Eichhorst, Barbara, Fürstenau, Moritz, Hallek, Michael
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2019
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913464/
https://ncbi.nlm.nih.gov/pubmed/31808867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000070
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!